0001140361-14-032838.txt : 20140814 0001140361-14-032838.hdr.sgml : 20140814 20140814162653 ACCESSION NUMBER: 0001140361-14-032838 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140813 FILED AS OF DATE: 20140814 DATE AS OF CHANGE: 20140814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Benjamin Howard CENTRAL INDEX KEY: 0001393547 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 141043280 MAIL ADDRESS: STREET 1: 401 MARRETT ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc1.xml FORM 4 X0306 4 2014-08-13 0 0000730272 REPLIGEN CORP RGEN 0001393547 Benjamin Howard C/O REPLIGEN CORPORATION 41 SEYON ST, BLDG 1, STE 100 WALTHAM MA 02453 0 1 0 0 VP Business Development Common Stock 2014-08-13 4 M 0 5000 3.33 A 113851 D Common Stcok 2014-08-13 4 S 0 40000 20.3448 D 73851 D Stock Option (Right to Buy) 3.33 2014-08-13 4 M 0 5000 0 D 2011-07-15 2020-07-15 Common Stock 5000 5000 D $20.3448 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.02 to $20.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Jeffrey P. Leduc (Attorney in Fact) 2014-08-14 EX-24 2 poa1.htm POWER OF ATTORNEY Unassociated Document
POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Walter C. Herlihy, Anthony J. Hunt, and Jeffrey P. Leduc, and any one of them acting singly, the true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the undersigned and in the undersigned's name, place and stead, in any and all capacities (until revoked in writing) to execute for and on behalf of the undersigned, in any and all of the undersigned's capacities, any and all statements on Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by Repligen Corporation (the "Company") in accordance with Sections 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and any and all regulations promulgated thereunder, and to file the same, with all exhibits thereto, and any other documents in connection therewith, with the Securities and Exchange Commission, and with any other entity when and if such is mandated by the Exchange Act or by the By-laws of the Financial Industry Regulatory Authority, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary fully to all intents and purposes as the undersigned might or could do in person thereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.

IN WITNESS WHEREOF, this Power of Attorney has been signed as of August 14, 2014.

 
/s/ Howard Benjamin
 
Name: Howard Benjamin